Loading clinical trials...
Loading clinical trials...
This study is being conducted to compare the effectiveness of the combination of valtorcitabine and telbivudine to telbivudine alone in patients with chronic hepatitis B.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
Collaborators
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT02932150 · Chronic Hepatitis B
NCT07024641 · Hepatitis B Virus Infection
NCT05856890 · Hepatitis b Virus, Hepatitis B
NCT06671093 · Chronic Hep B, Chronic Hepatitis b, and more
Pokfulam
Auckland
Singapore
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions